EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Gemcitabine–De Gramont Regimen In The Treatment Of Hepatocellular Carcinoma

Tarek Hashem, Khaled Abd El-Aziz, Tounis Ahmed, Hassan Metwaly, Mohamed Al-Sherbiny, Ashraf Abd El-Ghany, Eman Tawfeek, Naser Abd El-Bary, Rehab Ahmed

Research in Oncology · 2006

DOI: 10.21608/resoncol.2006.357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research in Oncology, 2006. Verfasst von Tarek Hashem und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hashem, T., El-Aziz, K. A., Ahmed, T., Metwaly, H., Al-Sherbiny, M., El-Ghany, A. A., Tawfeek, E., El-Bary, N. A., & Ahmed, R. (2006). Evaluation of Gemcitabine–De Gramont Regimen In The Treatment Of Hepatocellular Carcinoma. Research in Oncology. https://doi.org/10.21608/resoncol.2006.357

Vancouver

Hashem T, El-Aziz KA, Ahmed T, Metwaly H, Al-Sherbiny M, El-Ghany AA, et al. Evaluation of Gemcitabine–De Gramont Regimen In The Treatment Of Hepatocellular Carcinoma. Research in Oncology. 2006. doi:10.21608/resoncol.2006.357

BibTeX
@article{Hashem2006,
  author = {Hashem, Tarek and El-Aziz, Khaled Abd and Ahmed, Tounis and Metwaly, Hassan and Al-Sherbiny, Mohamed and El-Ghany, Ashraf Abd and Tawfeek, Eman and El-Bary, Naser Abd and Ahmed, Rehab},
  title = {Evaluation of Gemcitabine–De Gramont Regimen In The Treatment Of Hepatocellular Carcinoma},
  journal = {Research in Oncology},
  year = {2006},
  doi = {10.21608/resoncol.2006.357}
}
Kostenlos starten →